Organ Transplant Recipients
📧 Sign up to get email alerts when something new happens for Organ Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients [Phase 2]
Phase 2 trial updating Difluoromethylornithine (DFMO) for chemoprevention of skin cancer in organ transplant recipients has completed.